LoginSignup
AbbVie logo

AbbVie

Stock
Stock
ISIN: US00287Y1091
Ticker: ABBV
US00287Y1091
ABBV

Price

Price

Historical dividends and forecast

All dividend data

AbbVie has so far distributed $6.20 in 2024. The next dividend will be paid on 14.02.2025

$3.997

CHART BY

Frequently asked questions

What is AbbVie's market capitalization?

The market capitalization of AbbVie is $306.37B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is AbbVie's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for AbbVie is 60.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for AbbVie?

AbbVie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.866. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for AbbVie's stock?

Currently, 28 analysts cover AbbVie's stock, with a consensus target price of $186.33. Analyst ratings provide insights into the stock's expected performance.

What is AbbVie's revenue over the trailing twelve months?

Over the trailing twelve months, AbbVie reported a revenue of $55.53B.

Is AbbVie paying dividends?

Yes, AbbVie is paying dividends. The next payment is scheduled for 14.02.2025, with an expected amount of .

What is the EBITDA for AbbVie?

AbbVie's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $23.98B. EBITDA measures the company's overall financial performance.

What is the free cash flow of AbbVie?

AbbVie has a free cash flow of $4.72B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of AbbVie's stock?

The 5-year beta for AbbVie is 0.57. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does AbbVie have, and what sector and industry does it belong to?

AbbVie employs approximately 50,000 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of AbbVie's shares?

The free float of AbbVie is 1.77B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $306.37B

5Y beta

 0.57

EPS (TTM)

 $2.866

Free Float

 1.77B

P/E ratio (TTM)

 60.48

Revenue (TTM)

 $55.53B

EBITDA (TTM)

 $23.98B

Free Cashflow (TTM)

 $4.72B

Pricing

1D span
$171.97$174.76
52W span
$151.29$207.18

Analyst Ratings

The price target is $186.33 and the stock is covered by 28 analysts.

Buy

20

Hold

8

Sell

0

Information

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It researches and develops, manufactures, commercializes and sells medicines and therapies. Its product portfolio includes immunology, oncology, aesthetics, neuroscience, eye care and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia and Diffuse large B-cell lymphoma. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers and others. Its NX-13 for the treatment of ulcerative colitis and Crohn's disease. Its CEL383 for the treatment of inflammatory bowel disease. Its ALIA-1758 for the treatment of patients with Alzheimer's disease.

50,000

Biotechnology & Drugs

Health Care

Identifier

ISIN

US00287Y1091

Primary Ticker

ABBV

Knockouts

Join the conversation
Sign upLogin